CYP 6.38% 25.0¢ cynata therapeutics limited

cell & gene investor day, page-3

  1. 463 Posts.
    lightbulb Created with Sketch. 142
    Just to reiterate

    Cynata Overall response rate at day 100 from cohort A in adults was 100%

    From the Mesoblast presentation at the completion of their paediatric trial had an overall response rate of 69%
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.